Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Is a centrally acting skeletal muscle relaxant with depressant effect on the central nervous system.
Oral administration 4 times a day.
At latest update no relevant data on this subject were found in connection with breastfeeding.
Despite excretion into breast milk is likely, the elimination rate is quite rapid.
Whenever possible use a minimal dose and let it to pass two hours until the next feed.
Watch for occurrence of symptoms like sedation and feeding refusal in the infant.
Avoid in infants younger than one month of age.